IHI Corporation logo

IHI Corporation (IHICY)

Market Closed
5 Dec, 20:00
OTC PINK OTC PINK
$
19. 56
-0.68
-3.36%
$
16.04B Market Cap
- P/E Ratio
200% Div Yield
9,100 Volume
0 Eps
$ 20.24
Previous Close
Day Range
19.49 20.19
Year Range
6.78 32.52
Want to track IHICY and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Earnings results expected in 59 days
Are Industrial Products Stocks Lagging IHI CORP (IHICY) This Year?

Are Industrial Products Stocks Lagging IHI CORP (IHICY) This Year?

Here is how IHI CORP (IHICY) and Mitsubishi Heavy Industries, Ltd. (MHVYF) have performed compared to their sector so far this year.

Zacks | 1 year ago
IHI: A Pricey P/E But Bullish Chart Setup

IHI: A Pricey P/E But Bullish Chart Setup

Health Care sector at 52-week highs, led by Eli Lilly. Hold rating on iShares U.S. Medical Devices ETF (IHI) due to high valuation and secular headwinds. IHI has strong chart setup but high valuation, concentration risk, and weak seasonal trends; resistance at $59, support at $53-$54.

Seekingalpha | 1 year ago
Is IHI CORP (IHICY) Stock Outpacing Its Industrial Products Peers This Year?

Is IHI CORP (IHICY) Stock Outpacing Its Industrial Products Peers This Year?

Here is how IHI CORP (IHICY) and Mitsubishi Heavy Industries, Ltd. (MHVYF) have performed compared to their sector so far this year.

Zacks | 1 year ago
IHI CORP (IHICY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

IHI CORP (IHICY) Forms 'Hammer Chart Pattern': Time for Bottom Fishing?

IHI CORP (IHICY) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.

Zacks | 1 year ago
IHI: Despite Steady Returns At Current Prices, ETF Is Fairly Valued

IHI: Despite Steady Returns At Current Prices, ETF Is Fairly Valued

iShares U.S. Medical Devices ETF has underperformed in recent times. The healthcare sector is considered defensive, but medical devices may still be sensitive to economic downturns. IHI's present valuation is, in my opinion, fair (unlike at the end of 2021), but there are still concentration risks and little margin of safety in earnings growth numbers.

Seekingalpha | 1 year ago